Human monoclonal antibody human CD134 (OX40) and methods of making and using same

Details for Australian Patent Application No. 2006318329 (hide)

Owner La Jolla Institute for Allergy and Immunology Kirin Pharma Kabushiki Kaisha

Inventors Yoshida, Hitoshi; Soloff Nugent, Rachel; Croft, Michael; Kato, Shinichiro

Agent FB Rice

Pub. Number AU-B-2006318329

PCT Pub. Number WO2007/062245

Priority 60/739,659 25.11.05 US

Filing date 27 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 22 September 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/062245 Priority application(s): WO2007/062245

22 September 2011 Application Accepted

  Published as AU-B-2006318329

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006318333-Potent compstatin analogs

2006318327-Serum-free expansion of cells in culture